Bruker delivered an 11.0% increase in revenue in Q1 2025, supported by acquisitions and moderate organic growth. Despite strong execution, the company reported a sharp decline in GAAP net income and EPS due to integration costs from 2024 acquisitions. Operating margin expanded on a non-GAAP basis thanks to proactive cost management. The company revised its FY2025 guidance downward due to academic market weakness and tariff impacts.
Revenue rose 11.0% YoY to $801,400,000, including 2.9% organic growth.
GAAP EPS dropped to $0.11, while non-GAAP EPS was $0.47.
Net income fell significantly to $17,400,000 from $50,900,000 a year ago.
Non-GAAP operating income improved slightly to $101,700,000 despite acquisition-related headwinds.
Bruker adjusted its FY2025 guidance downward due to macroeconomic uncertainties, tariffs, and academic market weakness, but expects long-term margin expansion and EPS growth to resume in 2026.
Visualization of income flow from segment revenue to net income